Table of Contents Chapter 1 Overview of Asthma Drugs 1.1 Definition of Asthma Drugs in This Report 1.2 Commercial Types of Asthma Drugs 1.2.1 Long-term Control Medications 1.2.2 Quick-relief Medications (Rescue Medications) 1.2.3 Medications for Allergy-induced Asthma 1.3 Downstream Application of Asthma Drugs 1.3.1 Hospital Pharmacy 1.3.2 Retail Pharmacy 1.3.3 Online Pharmacy 1.4 Development History of Asthma Drugs 1.5 Market Status and Trend of Asthma Drugs 2013-2023 1.5.1 United States Asthma Drugs Market Status and Trend 2013-2023 1.5.2 Regional Asthma Drugs Market Status and Trend 2013-2023 Chapter 2 United States Market Status and Forecast by Regions 2.1 Market Status of Asthma Drugs in United States 2013-2017 2.2 Consumption Market of Asthma Drugs in United States by Regions 2.2.1 Consumption Volume of Asthma Drugs in United States by Regions 2.2.2 Revenue of Asthma Drugs in United States by Regions 2.3 Market Analysis of Asthma Drugs in United States by Regions 2.3.1 Market Analysis of Asthma Drugs in New England 2013-2017 2.3.2 Market Analysis of Asthma Drugs in The Middle Atlantic 2013-2017 2.3.3 Market Analysis of Asthma Drugs in The Midwest 2013-2017 2.3.4 Market Analysis of Asthma Drugs in The West 2013-2017 2.3.5 Market Analysis of Asthma Drugs in The South 2013-2017 2.3.6 Market Analysis of Asthma Drugs in Southwest 2013-2017 2.4 Market Development Forecast of Asthma Drugs in United States 2018-2023 2.4.1 Market Development Forecast of Asthma Drugs in United States 2018-2023 2.4.2 Market Development Forecast of Asthma Drugs by Regions 2018-2023 Chapter 3 United States Market Status and Forecast by Types 3.1 Whole United States Market Status by Types 3.1.1 Consumption Volume of Asthma Drugs in United States by Types 3.1.2 Revenue of Asthma Drugs in United States by Types 3.2 United States Market Status by Types in Major Countries 3.2.1 Market Status by Types in New England 3.2.2 Market Status by Types in The Middle Atlantic 3.2.3 Market Status by Types in The Midwest 3.2.4 Market Status by Types in The West 3.2.5 Market Status by Types in The South 3.2.6 Market Status by Types in Southwest 3.3 Market Forecast of Asthma Drugs in United States by Types Chapter 4 United States Market Status and Forecast by Downstream Industry 4.1 Demand Volume of Asthma Drugs in United States by Downstream Industry 4.2 Demand Volume of Asthma Drugs by Downstream Industry in Major Countries 4.2.1 Demand Volume of Asthma Drugs by Downstream Industry in New England 4.2.2 Demand Volume of Asthma Drugs by Downstream Industry in The Middle Atlantic 4.2.3 Demand Volume of Asthma Drugs by Downstream Industry in The Midwest 4.2.4 Demand Volume of Asthma Drugs by Downstream Industry in The West 4.2.5 Demand Volume of Asthma Drugs by Downstream Industry in The South 4.2.6 Demand Volume of Asthma Drugs by Downstream Industry in Southwest 4.3 Market Forecast of Asthma Drugs in United States by Downstream Industry Chapter 5 Market Driving Factor Analysis of Asthma Drugs 5.1 United States Economy Situation and Trend Overview 5.2 Asthma Drugs Downstream Industry Situation and Trend Overview Chapter 6 Asthma Drugs Market Competition Status by Major Players in United States 6.1 Sales Volume of Asthma Drugs in United States by Major Players 6.2 Revenue of Asthma Drugs in United States by Major Players 6.3 Basic Information of Asthma Drugs by Major Players 6.3.1 Headquarters Location and Established Time of Asthma Drugs Major Players 6.3.2 Employees and Revenue Level of Asthma Drugs Major Players 6.4 Market Competition News and Trend 6.4.1 Merger, Consolidation or Acquisition News 6.4.2 Investment or Disinvestment News 6.4.3 New Product Development and Launch Chapter 7 Asthma Drugs Major Manufacturers Introduction and Market Data 7.1 GlaxoSmithKline 7.1.1 Company profile 7.1.2 Representative Asthma Drugs Product 7.1.3 Asthma Drugs Sales, Revenue, Price and Gross Margin of GlaxoSmithKline 7.2 Sanofi 7.2.1 Company profile 7.2.2 Representative Asthma Drugs Product 7.2.3 Asthma Drugs Sales, Revenue, Price and Gross Margin of Sanofi 7.3 Roche & Novartis 7.3.1 Company profile 7.3.2 Representative Asthma Drugs Product 7.3.3 Asthma Drugs Sales, Revenue, Price and Gross Margin of Roche & Novartis 7.4 Teva 7.4.1 Company profile 7.4.2 Representative Asthma Drugs Product 7.4.3 Asthma Drugs Sales, Revenue, Price and Gross Margin of Teva 7.5 Merck 7.5.1 Company profile 7.5.2 Representative Asthma Drugs Product 7.5.3 Asthma Drugs Sales, Revenue, Price and Gross Margin of Merck 7.6 AstraZeneca 7.6.1 Company profile 7.6.2 Representative Asthma Drugs Product 7.6.3 Asthma Drugs Sales, Revenue, Price and Gross Margin of AstraZeneca 7.7 Boehringer Ingelheim 7.7.1 Company profile 7.7.2 Representative Asthma Drugs Product 7.7.3 Asthma Drugs Sales, Revenue, Price and Gross Margin of Boehringer Ingelheim Chapter 8 Upstream and Downstream Market Analysis of Asthma Drugs 8.1 Industry Chain of Asthma Drugs 8.2 Upstream Market and Representative Companies Analysis 8.3 Downstream Market and Representative Companies Analysis Chapter 9 Cost and Gross Margin Analysis of Asthma Drugs 9.1 Cost Structure Analysis of Asthma Drugs 9.2 Raw Materials Cost Analysis of Asthma Drugs 9.3 Labor Cost Analysis of Asthma Drugs 9.4 Manufacturing Expenses Analysis of Asthma Drugs Chapter 10 Marketing Status Analysis of Asthma Drugs 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.1.3 Marketing Channel Development Trend 10.2 Market Positioning 10.2.1 Pricing Strategy 10.2.2 Brand Strategy 10.2.3 Target Client 10.3 Distributors/Traders List Chapter 11 Report Conclusion Chapter 12 Research Methodology and Reference 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Reference

List of Tables Table Advantage and Disadvantage of Long-term Control Medications Table Advantage and Disadvantage of Quick-relief Medications (Rescue Medications) Table Advantage and Disadvantage of Medications for Allergy-induced Asthma Table Consumption Volume of Asthma Drugs in United States by Regions 2013-2017 Table Revenue of Asthma Drugs in United States by Regions 2013-2017 Table Consumption Volume of Asthma Drugs in United States by Regions 2018-2023 Table Revenue of Asthma Drugs in United States by Regions 2018-2023 Table Consumption Volume of Asthma Drugs in United States by Types 2013-2017 Table Revenue of Asthma Drugs in United States by Types 2013-2017 Table Consumption Volume of Asthma Drugs by Types in New England 2013-2017 Table Consumption Volume of Asthma Drugs by Types in The Middle Atlantic 2013-2017 Table Consumption Volume of Asthma Drugs by Types in The Midwest 2013-2017 Table Consumption Volume of Asthma Drugs by Types in The West 2013-2017 Table Consumption Volume of Asthma Drugs by Types in The South 2013-2017 Table Consumption Volume of Asthma Drugs by Types in Southwest 2013-2017 Table Consumption Volume Forecast of Asthma Drugs in United States by Types 2018-2023 Table Revenue Forecast of Asthma Drugs in United States by Types 2018-2023 Table Demand Volume of Asthma Drugs in United States by Downstream Industry 2013-2017 Table Demand Volume of Asthma Drugs by Downstream Industry in New England 2013-2017 Table Demand Volume of Asthma Drugs by Downstream Industry in The Middle Atlantic 2013-2017 Table Demand Volume of Asthma Drugs by Downstream Industry in The Midwest 2013-2017 Table Demand Volume of Asthma Drugs by Downstream Industry in The West 2013-2017 Table Demand Volume of Asthma Drugs by Downstream Industry in The South 2013-2017 Table Demand Volume of Asthma Drugs by Downstream Industry in Southwest 2013-2017 Table Demand Volume Forecast of Asthma Drugs in United States by Downstream Industry 2018-2023 Table Sales Volume of Asthma Drugs in United States by Major Players 2013-2017 Table Revenue of Asthma Drugs in United States by Major Players 2013-2017 Table Headquarters Location and Established Time of Asthma Drugs Major Players Table Employees and Revenue Level of Asthma Drugs Major Players Table Representative Asthma Drugs Product One of GlaxoSmithKline Table Representative Asthma Drugs Product Two of GlaxoSmithKline Table Asthma Drugs Sales, Revenue, Price and Gross Margin of GlaxoSmithKline 2013-2017 Table Representative Asthma Drugs Product One of Sanofi Table Representative Asthma Drugs Product Two of Sanofi Table Asthma Drugs Sales, Revenue, Price and Gross Margin of Sanofi 2013-2017 Table Representative Asthma Drugs Product One of Roche & Novartis Table Representative Asthma Drugs Product Two of Roche & Novartis Table Asthma Drugs Sales, Revenue, Price and Gross Margin of Roche & Novartis 2013-2017 Table Representative Asthma Drugs Product One of Teva Table Representative Asthma Drugs Product Two of Teva Table Asthma Drugs Sales, Revenue, Price and Gross Margin of Teva 2013-2017 Table Representative Asthma Drugs Product One of Merck Table Representative Asthma Drugs Product Two of Merck Table Asthma Drugs Sales, Revenue, Price and Gross Margin of Merck 2013-2017 Table Representative Asthma Drugs Product One of AstraZeneca Table Representative Asthma Drugs Product Two of AstraZeneca Table Asthma Drugs Sales, Revenue, Price and Gross Margin of AstraZeneca 2013-2017 Table Representative Asthma Drugs Product One of Boehringer Ingelheim Table Representative Asthma Drugs Product Two of Boehringer Ingelheim Table Asthma Drugs Sales, Revenue, Price and Gross Margin of Boehringer Ingelheim 2013-2017